Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cheine, Maxim V.
Wahlbeck, Kristian
and
Rimón, Mnan
1999.
Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis.
International Journal of Psychiatry in Clinical Practice,
Vol. 3,
Issue. 3,
p.
159.
Morris, S
Bagnall, A
Cooper, SJ
DeSilva, P
Fenton, M
Gammelin, GO
Leitner, M
and
Morris, Susan
2000.
Cochrane Database of Systematic Reviews.
Murphy, BE
Bagnall, A
Chue, P
Fenton, M
Leitner, M
Wood, J
and
Murphy, Brendan Eugene
2000.
Cochrane Database of Systematic Reviews.
Lewis, R
Bagnall, A-M
and
Leitner, M
2000.
Cochrane Database of Systematic Reviews.
Bagnall, Anne-Marie
Kleijnen, Jos
Leitner, Maria
and
Lewis, Ruth
2000.
Ziprasidone for schizophrenia and severe mental illness.
Cochrane Database of Systematic Reviews,
Tuunainen, Arja
and
Wahlbeck, Kristian
2000.
Newer atypical antipsychotic medication versus clozapine for schizophrenia.
Cochrane Database of Systematic Reviews,
Bagnall, A-M
Fenton, M
Lewis, R
Leitner, ML
Kleijnen, J
and
Bagnall, Anne-Marie
2000.
The Cochrane Database of Systematic Reviews.
Jones, Adrian
2001.
Hospital care pathways for patients with schizophrenia.
Journal of Clinical Nursing,
Vol. 10,
Issue. 1,
p.
58.
Laskowski, Cheryl
2001.
THE MENTAL HEALTH CLINICAL NURSE SPECIALIST AND THE "DIFFICULT" PATIENT: EVOLVING MEANING.
Issues in Mental Health Nursing,
Vol. 22,
Issue. 1,
p.
5.
Jones, A.
2002.
Assertive community treatment: development of the team, selection of clients, and impact on length of hospital stay.
Journal of Psychiatric and Mental Health Nursing,
Vol. 9,
Issue. 3,
p.
261.
Eikelmann, B.
and
Zacharias, B.
2003.
Psychiatrie und Psychotherapie.
p.
208.
COFFEY, M.
HIGGON, J.
and
KINNEAR, J.
2004.
‘Therapy as well as the tablets’: an exploratory study of service users’ views of community mental health nurses’ (CMHNs) responses to hearing voices.
Journal of Psychiatric and Mental Health Nursing,
Vol. 11,
Issue. 4,
p.
435.
Ban, Thomas A.
2004.
Neuropsychopharmacology and the genetics of schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 28,
Issue. 5,
p.
753.
Lewis, Ruth
Bagnall, Anne-Marie
and
Leitner, Maria
2005.
Sertindole for schizophrenia.
Cochrane Database of Systematic Reviews,
Kerwin, Rob W.
and
Bolonna, Anusha
2005.
Management of clozapine-resistant schizophrenia.
Advances in Psychiatric Treatment,
Vol. 11,
Issue. 2,
p.
101.
Arranz, Maria
Mancama, Dalu
and
Kerwin, Robert
2006.
Pharmacogenetics.
p.
295.
Wheeler, Amanda
Humberstone, Verity
and
Robinson, Gail
2006.
Trends in Antipsychotic Prescribing in Schizophrenia in Auckland.
Australasian Psychiatry,
Vol. 14,
Issue. 2,
p.
169.
DeSilva, Prasanna
Fenton, Mark
and
Rathbone, John
2006.
Zotepine for schizophrenia.
Cochrane Database of Systematic Reviews,
Wheeler, Amanda
Humberstone, Verity
and
Robinson, Gail
2006.
Trends in Antipsychotic Prescribing in Schizophrenia in Auckland.
Australasian Psychiatry,
Vol. 14,
Issue. 2,
p.
169.
Bagnall, Anne-Marie
Fenton, Mark
Kleijnen, Jos
and
Lewis, Ruth
2007.
Molindone for schizophrenia and severe mental illness.
Cochrane Database of Systematic Reviews,
eLetters
No eLetters have been published for this article.